![Kirk D. Schumacher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kirk D. Schumacher
Nessuna posizione attualmente
Profilo
Kirk D.
Schumacher worked as the General Counsel, SVP-Legal Affairs & Compliance at Seagen Inc. from 2014 to 2014.
Prior to that, he was a Senior Attorney at Venture Law Group and the Principal at Kds Law Group.
He also served as the Senior Vice President & General Counsel at Chinook Therapeutics, Inc. Mr. Schumacher holds a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Wisconsin.
Precedenti posizioni note di Kirk D. Schumacher
Società | Posizione | Fine |
---|---|---|
CHINOOK THERAPEUTICS, INC. | Consigliere Generale | 01/09/2023 |
SEAGEN INC. | Responsabile della Conformità | 26/11/2014 |
Kds Law Group | Corporate Officer/Principal | - |
Venture Law Group
![]() Venture Law Group Miscellaneous Commercial ServicesCommercial Services Venture Law Group provided law and legal services. The firm specialized in mergers and acquisitions, bankruptcy and restructuring, taxation, labor and employment, intellectual property, technology licensing, corporate partnerships, and executive compensation. The company was founded in 1993 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | - |
Formazione di Kirk D. Schumacher
The Trustees of Columbia University in The City of New York | Graduate Degree |
University of Wisconsin | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Seagen Inc.
![]() Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Venture Law Group
![]() Venture Law Group Miscellaneous Commercial ServicesCommercial Services Venture Law Group provided law and legal services. The firm specialized in mergers and acquisitions, bankruptcy and restructuring, taxation, labor and employment, intellectual property, technology licensing, corporate partnerships, and executive compensation. The company was founded in 1993 and is headquartered in Menlo Park, CA. | Commercial Services |
Chinook Therapeutics, Inc.
![]() Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
Kds Law Group |
- Borsa valori
- Insiders
- Kirk D. Schumacher